Who
Edward M. Gillis
Senior Vice President, Devices
Company insider
Files Form 4 as: Senior Vice President, Devices, BioCardia.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $6,514
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Apr 2021
- Last trade
- 6 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,442 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,442 at $0.00 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $21K17,269 at $1.24 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $21K17,269 at $1.24 | filing |
| 29 Jun 2026filed 1 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $47K39,521 at $1.20 | filing |
| 29 Jun 2026filed 1 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $47K39,521 at $1.20 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $52K38,078 at $1.37 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $21K15,172 at $1.37 | filing |
| 20 Dec 2024filed 26 Dec 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Sold | $6,5143,257 at $2.00 | filing |
| 11 Oct 2024filed 16 Oct 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $42K15,808 at $2.65 | filing |
| 11 Oct 2024filed 16 Oct 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $18K6,840 at $2.65 | filing |
| 31 May 2023filed 2 Jun 2023 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $27K15,512 at $1.77 | filing |
| 18 May 2023filed 22 May 2023 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,803 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $69K40,490 at $1.70 | filing |
| 12 May 2022filed 18 May 2022 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $16K12,358 at $1.32 | filing |
| 14 Apr 2022filed 18 Apr 2022 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 14 Apr 2022filed 18 Apr 2022 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —30,155 at $0.00 | filing |
| 10 Jun 2021filed 11 Jun 2021 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $43K9,953 at $4.35 | filing |
| 21 Apr 2021filed 27 Apr 2021 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,670 at $0.00 | filing |
News
BioCardia (NASDAQ:BCDA) Stock Falls 5.5% – What's Next?BCDA · dailypolitical.com · 23 Oct 2026BioCardia Advances Helix Catheter Toward FDA Marketing ClearanceBCDA · rttnews.com · 19 Oct 2026
0 headlines in the last 90 days name Edward M. Gillis; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.